Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

November 30, 2011

Conditions
Stroke
Interventions
DRUG

citicoline

citicoline IV 2000 mg, then citicoline 900 mg/day (300mg\*3 times per day) per os

DRUG

L-Alpha glycerylphosphorylcholine

choline alfoscerate IV 1000mg daily 10 days

DRUG

cerebrolysin

Cerebrolysin IV 10 ml daily 10 days

Trial Locations (1)

620102

Clinical Institute of Brain, Yekaterinburg

All Listed Sponsors
collaborator

Nycomed

INDUSTRY

collaborator

Veropharm

INDUSTRY

collaborator

Ever Neuro Pharma GmbH

INDUSTRY

lead

Clinical Institute of the Brain, Russia

OTHER